Clinical trial
Combination Chemotherapy in Treating Patients With Locally Advanced or…
NCT00003810 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003810 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas |
| Official title | A Phase II Study of Gemcitabine and Docetaxel in Pancreatic Adenocarcinoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, gemcitabine hydrochloride |
| Start date | Aug 11, 1999 |
| Primary completion | May 1, 2002 |
| First posted | Aug 4, 2004 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: